Royal College of Pathologists Urges New Zealand to Reconsider Cigarette Sales Ban

Regulations by 2FIRSTS.ai
Dec.04.2023
Royal College of Pathologists Urges New Zealand to Reconsider Cigarette Sales Ban
Australian Royal College of Pathologists urges New Zealand government to reconsider plans to reverse ban on cigarette sales.

According to media outlet scoop.co.nz, the Royal College of Pathologists of Australasia (RCPA) has called for the New Zealand government to reconsider its decision to repeal a law banning the sale of cigarettes nationwide.

 

Dr. Elizabeth Roberts, the Deputy Director of the Royal College of Pathologists of Australia and New Zealand, believes that this is a setback for public health.

 

She stated that smoking is the leading preventable cause of death in New Zealand, and the previous government's legislation provided opportunities for disease prevention, reduction and saving lives, particularly benefiting the Māori population who face health inequalities. New Zealand was set to become the first country in the world to achieve a "smoke-free generation," making the current government's change of direction difficult to comprehend.

 

According to reports, the original measures included banning the sale of tobacco to individuals born after January 1, 2009, limiting nicotine content in tobacco products, and reducing tobacco retailers by over 90%.

 

Dr. Roberts expressed his deep anguish, saying, "We had believed that the goal of a smoke-free 2025 seemed within our grasp, but now it feels out of reach. We urge the government to reconsider its decision to lift the ban.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Interview with Germany’s BfTG: 40% of Market Lost to Illicit Trade, Industry Calls for Smarter Regulation
Interview with Germany’s BfTG: 40% of Market Lost to Illicit Trade, Industry Calls for Smarter Regulation
At the InterTabac trade show in Dortmund, Philip Drögemüller, Managing Director of Germany’s Smoke-Free Alliance (BfTG), spoke with 2Firsts. He said Germany’s vaping market still has substantial potential, but the industry faces policy uncertainty and compliance pressure. The association urges companies to operate compliantly and to shift from disposable products to rechargeable systems as early as possible to prepare for the structural adjustments brought by the EU battery rules in 2027.
Sep.20 by 2FIRSTS.ai
British American Tobacco France: A complete ban on tobacco-free nicotine pouches could drive the expansion of the black market
British American Tobacco France: A complete ban on tobacco-free nicotine pouches could drive the expansion of the black market
British American Tobacco (BAT) France expressed opposition to the government's plan to ban tobacco-free nicotine pouches in the National Assembly, arguing that a ban would foster a vibrant black market and harm public health and the protection of minors. The company also cited the examples of Sweden and New Zealand, which have reduced smoking rates through "clear regulations and strict controls," and proposed three policy recommendations: ban sales to minors, strictly regulate smokeless nicotine
Sep.26 by 2FIRSTS.ai
InterTabac 2025 Insights|Nicotine Pouches Reach 70mg/g, Cotton-Pad Oral Products Also on Display
InterTabac 2025 Insights|Nicotine Pouches Reach 70mg/g, Cotton-Pad Oral Products Also on Display
GARANT Nicotine Pouches at Inter Tabac 2025 At the Inter Tabac 2025 exhibition, GARANT showcased its new nicotine pouch line. According to on-site observations by 2Firsts, the brand unveiled nicotine pouches with concentrations up to 70mg/g, as well as mini pouches with a capacity of 35 per tin. The products featured a unique, square, cotton-pad shape.
Sep.23 by 2FIRSTS.ai
Indonesia’s BNN: No Full Vape Ban Like Singapore, Focus on Controlling Narcotics and Psychotropic Substances
Indonesia’s BNN: No Full Vape Ban Like Singapore, Focus on Controlling Narcotics and Psychotropic Substances
The Chief of Indonesia’s National Narcotics Agency (BNN), Marthinus Hukom, stated that Indonesia will not follow Singapore in imposing a total ban on e-cigarettes. Instead, the country will strengthen regulation on vape liquids containing narcotics or psychotropic substances. Recently, BNN confiscated about 1,800 vaping devices containing etomidate and ketamine, and the cases have been handed over to the Ministry of Health and the police.
Aug.22 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
2Firsts interviewed Imperial Brands on FDA’s blu denial. ITG Brands responded with disappointment, vowing to pursue a fair, science-based review.
Aug.22